Table 3.
Immunohistochemical profiles of NUT carcinoma, basaloid squamous cell carcinoma, and small cell carcinoma
| Case | NUT | CGA | SYN | CD56 | TTF-1 | P40 | CK5/6 | INSM1 | ASCL1 | BCL2 | ProGRP | Ki-67 | Abrupt keratinization | NUT split FISH |
Fusion variant |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NUT carcinoma (n = 8) | |||||||||||||||
| 1 | + | - | + a | -a | - | + a | - | w + | - | - | - | NE | - | NE | NE |
| 2 | + | - | - | - | - | - | - | w + | - | w + | - | 90 | - | positive | NE |
| 3 | + | - | - | - | - | w + | w + | w + | - | - | - | 80 | - | positive | NE |
| 4 | + | - | w + | - | - | - | - | w + | - | + | - | 50 | - | positive | BRD4-NUT |
| 5 | + | - | - | - | - | + | + | w + | - | - | - | 80 | + | positive | NE |
| 6 | + a | - | - | - | NE | NE | + a | NE | NE | NE | NE | NE | + | positive | NE |
| 7 | + a | NE | NE | NE | NE | + a | NE | NE | NE | NE | NE | NE | - | NE | NE |
| 8 | + | - | - | - | - | + | + | w + | - | w + | - | 70 | + | positive | BRD4-NUT |
| Basaloid squamous cell carcinoma (n = 8) | |||||||||||||||
| 1 | - | - | - | - | - | + | + | - | - | + | NE | 10 | |||
| 2 | - | - | - | - | - | + | + | - | - | + | NE | 20 | |||
| 3 | - | - | - | - | - | + | + | - | - | + | NE | 30 | |||
| 4 | - | - | - | - | - | + | + | - | - | + | NE | 10 | |||
| 5 | - | - | - | - | - | + | + | - | - | + | NE | 90 | |||
| 6 | - | - | - | w + | - | w + | + | - | - | + | NE | 60 | |||
| 7 | - | - | - | + | - | + | + | - | - | + | NE | 70 | |||
| 8 | - | - | - | - | - | + | + | w + | - | + | NE | 80 | |||
| Small cell carcinoma (n = 13) | |||||||||||||||
| 1 | - | + | + | + | + | - | - | + | + | + | - | 90 | |||
| 2 | - | w + | + | + | + | - | - | + | + | + | + | 90 | |||
| 3 | - | w + | + | + | + | w + | - | + | w + | w + | - | 85 | |||
| 4 | - | - | + | + | + | - | - | + | w + | + | + | 90 | |||
| 5 | - | - | + | + | + | - | - | + | - | + | - | 95 | |||
| 6 | - | w + | + | + | + | - | - | + | + | + | w + | 70 | |||
| 7 | - | w + | + | + | + | - | - | + | + | + | + | 95 | |||
| 8 | - | + | + | + | + | - | - | + | + | + | w + | 95 | |||
| 9 | - | w + | + | + | + | - | - | + | w + | + | w + | 90 | |||
| 10 | - | - | w + | + | + | - | - | + | + | + | - | 95 | |||
| 11 | - | - | - | - | - | - | - | w + | - | + | - | 95 | |||
| 12 | - | w + | + | + | + | - | - | + | + | + | w + | 80 | |||
| 13 | - | + | + | + | + | - | - | + | + | + | - | 100 | |||
CGA Chromogranin A, SYN Synaptophysin, NE Not examined
astained slides were not available. positive cells; 1%–10% (-), more than 10% ( +) positive ( +): H-score was ≥ 100, weakly positive (w +) when the H-score was between 5 and 100 and negative when the H-score was < 5